innoscripta Launches in UK to Disrupt R&D Tax Claims with Real-Time Clusterix Platform

Quick Summary

innoscripta solves the challenge of complex R&D tax claims for UK businesses by replacing manual spreadsheets with its Clusterix platform. This technology captures project data in real-time, ensuring audit-ready documentation that meets strict HMRC regulatory requirements while reducing administrative burden for innovative companies.

How Does innoscripta Solve Manual R&D Tax Claim Challenges?

innoscripta solves the R&D tax claims bottleneck by moving away from the traditional, retrospective consultancy model. Instead of reconstructing project details months after completion, the Clusterix platform allows businesses to capture R&D activity as it happens. This shift to real-time documentation ensures that technical uncertainties and qualifying costs are recorded accurately, providing a defensible audit trail for HMRC.

• Real-time data capture eliminates the need for year-end interviews.
• Automated project documentation reduces administrative time by significant margins.
• Continuous compliance monitoring aligns with the Merged R&D Expenditure Credit Scheme.

What Results Has the Clusterix Platform Delivered?

The Clusterix platform has already demonstrated significant impact across Europe, supporting over 2,500 companies in securing innovation funding. By utilizing technology-led tax strategy, businesses can move away from manual spreadsheet processes that often fail to secure maximum funding levels. The platform's success is evidenced by innoscripta's recognition as a Financial Times-recognised scale-up and its successful 2025 IPO.

• 2,500+ companies currently use the platform across Europe.
• Audit-ready evidence is generated automatically to satisfy regulatory scrutiny.
• International expansion now brings these proven efficiencies to the UK market.

How is innoscripta Supporting UK Business Growth?

To lead its UK market expansion, innoscripta has appointed Josh Perry as Head of Sales for the UK & Ireland. Perry brings over ten years of experience in R&D tax strategy, specifically helping firms align transatlantic R&D positions. This leadership, combined with the Clusterix platform, provides UK innovators with a smarter, seamless way to manage tax relief without distracting from core engineering and science activities.

FF NEWS TAKE:

The launch of innoscripta in the UK definitely moves the needle for the local fintech and tax-tech landscape. For too long, R&D tax claims have been a manual, high-friction process prone to HMRC rejection. By applying a SaaS-first approach to a consultancy-heavy sector, innoscripta is professionalizing innovation funding. This real-time documentation model is the only way businesses will survive increasing regulatory scrutiny in the post-reform era.